GINKGO BIOWORKS HOLDINGS, INC. Equity Securities, FV-NI, Unrealized Gain (Loss)
GINKGO BIOWORKS HOLDINGS, INC. (DNA) reported Equity Securities, FV-NI, Unrealized Gain (Loss) of $2.65 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Income Statement › Other Income
us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss · last filed 2026-02-26
- GINKGO BIOWORKS HOLDINGS, INC. equity securities, fv-ni, unrealized gain (loss) for the quarter ending 2024-12-31 was -$1.83M.
- GINKGO BIOWORKS HOLDINGS, INC. equity securities, fv-ni, unrealized gain (loss) for the quarter ending 2024-09-30 was -$6.91M.
- GINKGO BIOWORKS HOLDINGS, INC. equity securities, fv-ni, unrealized gain (loss) for the quarter ending 2023-12-31 was -$781.00K.
- GINKGO BIOWORKS HOLDINGS, INC. equity securities, fv-ni, unrealized gain (loss) for the quarter ending 2023-09-30 was -$1.70M.
- GINKGO BIOWORKS HOLDINGS, INC. equity securities, fv-ni, unrealized gain (loss) for fiscal 2025 was $2.65M.
- GINKGO BIOWORKS HOLDINGS, INC. equity securities, fv-ni, unrealized gain (loss) for fiscal 2024 was -$8.00M.
- GINKGO BIOWORKS HOLDINGS, INC. equity securities, fv-ni, unrealized gain (loss) for fiscal 2023 was -$9.16M.
- GINKGO BIOWORKS HOLDINGS, INC. equity securities, fv-ni, unrealized gain (loss) for fiscal 2022 was -$43.02M.
| Period end | Equity Securities, FV-NI, Unrealized Gain (Loss) 3 month | Equity Securities, FV-NI, Unrealized Gain (Loss) 6 month | Equity Securities, FV-NI, Unrealized Gain (Loss) 9 month | Equity Securities, FV-NI, Unrealized Gain (Loss) 12 month |
|---|---|---|---|---|
| 2025-12-31 | $2.65M 10-K · filed 2026-02-26 | |||
| 2024-12-31 | -$1.83M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$8.74M derived: sum of 2 quarters · filed 2026-02-26 | -$8.00M 10-K · filed 2026-02-26 | |
| 2024-09-30 | -$6.91M 10-Q · filed 2024-11-12 | -$6.17M 10-Q · filed 2024-11-12 | ||
| 2023-12-31 | -$781.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$2.48M derived: sum of 2 quarters · filed 2026-02-26 | -$9.16M 10-K · filed 2026-02-26 | |
| 2023-09-30 | -$1.70M 10-Q · filed 2024-11-12 | -$8.38M 10-Q · filed 2024-11-12 | ||
| 2022-12-31 | -$43.02M 10-K · filed 2025-02-25 |